(Q28423257)

English

HSPH1 T17 DELETION

genetic variant

T17 DELETION

In more languages

Statements

Short Tandem Repeat Variation

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/491

human chromosome 13

genomic assembly

Genome assembly GRCh37

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/491

31722621

genomic assembly

Genome assembly GRCh37

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/491

31722637

genomic assembly

Genome assembly GRCh37

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/491

biological variant of

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/491

positive therapeutic predictor for

fluorouracil / Oxaliplatin combination therapy

medical condition treated

colorectal cancer

determination method

CIViC evidence level B

CIViC 2-star trust rating

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/1164

Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy.

Identifiers

CIViC variant ID

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/491

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28423257&oldid=2014800887"